Dhiraj Kumar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dhiraj Kumar Singh has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Riyaz Ahmad Mir
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
2 shared publications - Anu Bhatia
PRIMSR Hospital, SRM University, Sonipat, India
1 shared publication - Kanika Makker
Division of Periodontics Centre for Dental Education and Research, All India Institute of Medical Sciences New Delhi India
1 shared publication - Qulsum Akhter Mir
Department of Higher Education, Govt of Jammu and Kashmir
1 shared publication - Rakhee Yadav
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
1 shared publication - Vikender Singh Yadav
Division of Periodontics, Centre for Dental Education and Research, All India Institute of Medical Sciences, New Delhi, India
1 shared publication
Latest Publications
- Open Access
A crucial role for PIH1D1 in modulating p53 stability via the R2TP complex
The R2TP is a multimeric protein complex consists of RUVBL1, RUVBL2, PIH1D1, and RPAP3, and it is known to functions as a specialized co-chaperone. We hypothesize that PIH1D1 recognizes p53 and stabilizes it via R2TP complex. Upon successful completion of this study, innovative mechanism has been found for the interaction and stabilization of p53 and hence govern the cell cycle. Upon interaction between p53 and PIH1D1 protein, p53 is stabilized by PIH1D1 protein, without affecting its C-terminal domain. We have also observed that p53 protein levels were affected after the alteration in expression levels of PIH1D1. Based on the finding, we suggest that the R2TP complex stabilizes and regulates P53. Therefore, this novel method will work as a flashpoint to restore the function of p53 in cancer cells, controlling cancer and cell cycle progression.
Open AccessA crucial role for PIH1D1 in modulating p53 stability via the R2TP complex
The R2TP is a multimeric protein complex consists of RUVBL1, RUVBL2, PIH1D1, and RPAP3, and it is known to functions as a specialized co-chaperone. We hypothesize that PIH1D1 recognizes p53 and stabilizes it via R2TP complex. Upon successful completion of this study, innovative mechanism has been found for the interaction and stabilization of p53 and hence govern the cell cycle. Upon interaction between p53 and PIH1D1 protein, p53 is stabilized by PIH1D1 protein, without affecting its C-terminal domain. We have also observed that p53 protein levels were affected after the alteration in expression levels of PIH1D1. Based on the finding, we suggest that the R2TP complex stabilizes and regulates P53. Therefore, this novel method will work as a flashpoint to restore the function of p53 in cancer cells, controlling cancer and cell cycle progression.
- 8 April 2024
- Published by Springer Nature in Odontology
- Vol. 112 (4) , 1353-1360
Effect of initial periodontal therapy on metallothionein levels in smokers and non-smokers with periodontitis
The aim of this study was to determine the effect of non-surgical periodontal therapy (NSPT) on mRNA expression of metallothionein (MT) and its levels in serum, saliva and gingival crevicular fluid (GCF) of smokers (S) and non-smokers (NS) with periodontitis (P). A total of 100 participants were included: 48 periodontally healthy (PH) subjects (24 S [PH + S] and 24 NS [PH + NS]) and 52 patients with P (27 S [P + S] and 25 NS [P + NS]). Clinical parameters were recorded, and biofluids (serum, saliva and GCF) and gingival tissue samples were obtained at baseline in all groups and 3 months after NSPT in P groups. MT levels in biofluids were determined by ELISA. In gingival tissues, MT-mRNA expression was quantified using real-time PCR. mRNA expression of MT and its levels in biofluids were significantly higher in P + S compared to other groups, and the differences between P + NS and PH + S were non-significant. A significant decrease was observed for MT levels in biofluids, and MT-mRNA expression in periodontitis patients after NSPT. In conclusion, smoking and periodontitis are associated with higher MT expression which decreases after NSPT. MT as an oxidative stress biomarker and its therapeutic role in periodontitis should be investigated in future studies. Clinical trial registration: The study was prospectively registered at Clinical Trials Registry—India (ctri.nic.in) as CTRI/2018/08/015427 on August 23, 2018.
- 8 April 2024
- Published by Springer Nature in Odontology
- Vol. 112 (4) , 1353-1360
Effect of initial periodontal therapy on metallothionein levels in smokers and non-smokers with periodontitis
The aim of this study was to determine the effect of non-surgical periodontal therapy (NSPT) on mRNA expression of metallothionein (MT) and its levels in serum, saliva and gingival crevicular fluid (GCF) of smokers (S) and non-smokers (NS) with periodontitis (P). A total of 100 participants were included: 48 periodontally healthy (PH) subjects (24 S [PH + S] and 24 NS [PH + NS]) and 52 patients with P (27 S [P + S] and 25 NS [P + NS]). Clinical parameters were recorded, and biofluids (serum, saliva and GCF) and gingival tissue samples were obtained at baseline in all groups and 3 months after NSPT in P groups. MT levels in biofluids were determined by ELISA. In gingival tissues, MT-mRNA expression was quantified using real-time PCR. mRNA expression of MT and its levels in biofluids were significantly higher in P + S compared to other groups, and the differences between P + NS and PH + S were non-significant. A significant decrease was observed for MT levels in biofluids, and MT-mRNA expression in periodontitis patients after NSPT. In conclusion, smoking and periodontitis are associated with higher MT expression which decreases after NSPT. MT as an oxidative stress biomarker and its therapeutic role in periodontitis should be investigated in future studies. Clinical trial registration: The study was prospectively registered at Clinical Trials Registry—India (ctri.nic.in) as CTRI/2018/08/015427 on August 23, 2018.